BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26194173)

  • 21. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
    Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
    Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
    Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
    Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting.
    Fromm JR; Kussick SJ; Wood BL
    Am J Clin Pathol; 2006 Nov; 126(5):764-80. PubMed ID: 17050074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative proteomic profiling of Hodgkin lymphoma cell lines.
    Vergara D; Simeone P; De Matteis S; Carloni S; Lanuti P; Marchisio M; Miscia S; Rizzello A; Napolitano R; Agostinelli C; Maffia M
    Mol Biosyst; 2016 Jan; 12(1):219-32. PubMed ID: 26588820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation.
    Bose S; Starczynski J; Chukwuma M; Baumforth K; Wei W; Morgan S; Byrd P; Ying J; Grundy R; Mann JR; Tao Q; Taylor AM; Murray PG; Stankovic T
    J Pathol; 2007 Nov; 213(3):329-36. PubMed ID: 17876757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
    Lennerz JK; Hoffmann K; Bubolz AM; Lessel D; Welke C; Rüther N; Viardot A; Möller P
    Oncotarget; 2015 Oct; 6(30):29097-110. PubMed ID: 26336985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
    Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
    J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma.
    Martín-Moreno AM; Roncador G; Maestre L; Mata E; Jiménez S; Martínez-Torrecuadrada JL; Reyes-García AI; Rubio C; Tomás JF; Estévez M; Pulford K; Piris MA; García JF
    PLoS One; 2015; 10(6):e0125203. PubMed ID: 26066800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.
    Mader A; Bruderlein S; Wegener S; Melzner I; Popov S; Muller-Hermelink HK; Barth TF; Viardot A; Moller P
    Cytogenet Genome Res; 2007; 119(3-4):204-10. PubMed ID: 18253030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
    Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
    Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.
    Liu WR; Shipp MA
    Blood; 2017 Nov; 130(21):2265-2270. PubMed ID: 29167175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma.
    Gomez F; Fisk B; McMichael JF; Mosior M; Foltz JA; Skidmore ZL; Duncavage EJ; Miller CA; Abel H; Li YS; Russler-Germain DA; Krysiak K; Watkins MP; Ramirez CA; Schmidt A; Martins Rodrigues F; Trani L; Khanna A; Wagner JA; Fulton RS; Fronick CC; O'Laughlin MD; Schappe T; Cashen AF; Mehta-Shah N; Kahl BS; Walker J; Bartlett NL; Griffith M; Fehniger TA; Griffith OL
    Cancer Res Commun; 2023 Nov; 3(11):2312-2330. PubMed ID: 37910143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA signature in classical Hodgkin lymphoma.
    Paczkowska J; Giefing M
    J Appl Genet; 2021 May; 62(2):281-288. PubMed ID: 33544339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.
    Liu WR; Shipp MA
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):310-316. PubMed ID: 29222272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation].
    Weniger MA; Melzner I; Menz CK; Wegener S; Bucur AJ; Dorsch K; Mattfeldt T; Barth TF; Möller P
    Verh Dtsch Ges Pathol; 2006; 90():210-5. PubMed ID: 17867599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imbalance of Pro- and Anti-Inflammatory Cytokines in Patients With cHL Persists Despite Treatment Compared With Control Subjects.
    da Silva PB; Perini GF; Pereira Lde A; Sacconato EM; Penna AM; Garibaldi J; Cavalcante E; Baiocchi OC
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S151-7. PubMed ID: 26297269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The molecular pathology of classical Hodgkin lymphoma].
    Asano N
    Rinsho Ketsueki; 2015 Oct; 56(10):2024-31. PubMed ID: 26458441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells.
    Zahn M; Marienfeld R; Melzner I; Heinrich J; Renner B; Wegener S; Mießner A; Barth TF; Dorsch K; Brüderlein S; Möller P
    Blood; 2017 Mar; 129(11):1480-1490. PubMed ID: 28082443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.